505 related articles for article (PubMed ID: 19593320)
41. Cardiometabolic features of polycystic ovary syndrome.
Hoffman LK; Ehrmann DA
Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):215-22. PubMed ID: 18250636
[TBL] [Abstract][Full Text] [Related]
42. [Long-term risks of polycystic ovaries syndrome].
Lefebvre P; Raingeard I; Renard E; Bringer J
Gynecol Obstet Fertil; 2004 Mar; 32(3):193-8. PubMed ID: 15123116
[TBL] [Abstract][Full Text] [Related]
43. Cardiovascular disease risk in women with PCOS.
Dokras A
Steroids; 2013 Aug; 78(8):773-6. PubMed ID: 23624351
[TBL] [Abstract][Full Text] [Related]
44. Hemostatic abnormalities and relationships to metabolic and hormonal status in polycystic ovarian syndrome.
Burchall G; Linden MD; Teede H; Piva TJ
Trends Cardiovasc Med; 2011 Jan; 21(1):6-14. PubMed ID: 22498014
[TBL] [Abstract][Full Text] [Related]
45. The reproductive phenotype in polycystic ovary syndrome.
Chang RJ
Nat Clin Pract Endocrinol Metab; 2007 Oct; 3(10):688-95. PubMed ID: 17893687
[TBL] [Abstract][Full Text] [Related]
46. A review of polycystic ovarian syndrome in adolescents.
Brewer M; Pawelczak M; Kessler M; Shah B
Minerva Pediatr; 2010 Oct; 62(5):459-73. PubMed ID: 20940680
[TBL] [Abstract][Full Text] [Related]
47. Polycystic ovary syndrome and the postmenopausal woman.
Ireland K; Child T
J Br Menopause Soc; 2006 Dec; 12(4):143-8. PubMed ID: 17178014
[TBL] [Abstract][Full Text] [Related]
48. Pathophysiology and types of dyslipidemia in PCOS.
Diamanti-Kandarakis E; Papavassiliou AG; Kandarakis SA; Chrousos GP
Trends Endocrinol Metab; 2007 Sep; 18(7):280-5. PubMed ID: 17692530
[TBL] [Abstract][Full Text] [Related]
49. Is the risk for cardiovascular disease increased in all phenotypes of the polycystic ovary syndrome?
Daskalopoulos GN; Karkanaki A; Karagiannis A; Mikhailidis DP; Athyros VG
Angiology; 2011 May; 62(4):285-90. PubMed ID: 21474465
[TBL] [Abstract][Full Text] [Related]
50. Long-term consequences of polycystic ovary syndrome on cardiovascular risk.
Rizzo M; Berneis K; Spinas G; Rini GB; Carmina E
Fertil Steril; 2009 Apr; 91(4 Suppl):1563-7. PubMed ID: 18976752
[TBL] [Abstract][Full Text] [Related]
51. Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome.
Lowenstein EJ
Dermatol Ther; 2006; 19(4):210-23. PubMed ID: 17004997
[TBL] [Abstract][Full Text] [Related]
52. Identification of appropriate patients for cardiometabolic risk management.
Peters AL
Rev Cardiovasc Med; 2007; 8 Suppl 4():S9-16. PubMed ID: 17934394
[TBL] [Abstract][Full Text] [Related]
53. Polycystic ovary syndrome, diabetes and cardiovascular disease: risks and risk factors.
Lakhani K; Prelevic GM; Seifalian AM; Atiomo WU; Hardiman P
J Obstet Gynaecol; 2004 Sep; 24(6):613-21. PubMed ID: 16147598
[TBL] [Abstract][Full Text] [Related]
54. Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype.
Rizzo M; Berneis K; Hersberger M; Pepe I; Di Fede G; Rini GB; Spinas GA; Carmina E
Hum Reprod; 2009 Sep; 24(9):2286-92. PubMed ID: 19454589
[TBL] [Abstract][Full Text] [Related]
55. Evaluating the medical literature in reproductive medicine: questions concerning prognosis.
Groll JM; Fritz MA
Semin Reprod Med; 2003 Feb; 21(1):27-37. PubMed ID: 12806557
[TBL] [Abstract][Full Text] [Related]
56. Polycystic ovarian syndrome and subclinical atherosclerosis among women of reproductive age in the Dallas heart study.
Chang AY; Ayers C; Minhajuddin A; Jain T; Nurenberg P; de Lemos JA; Wild RA; Auchus RJ
Clin Endocrinol (Oxf); 2011 Jan; 74(1):89-96. PubMed ID: 21044112
[TBL] [Abstract][Full Text] [Related]
57. Polycystic ovary syndrome and early-onset preeclampsia: reproductive manifestations of increased cardiovascular risk.
Veltman-Verhulst SM; van Rijn BB; Westerveld HE; Franx A; Bruinse HW; Fauser BC; Goverde AJ
Menopause; 2010; 17(5):990-6. PubMed ID: 20551845
[TBL] [Abstract][Full Text] [Related]
58. Polycystic ovary syndrome: validated questionnaire for use in diagnosis.
Pedersen SD; Brar S; Faris P; Corenblum B
Can Fam Physician; 2007 Jun; 53(6):1042-7, 1041. PubMed ID: 17872783
[TBL] [Abstract][Full Text] [Related]
59. The metabolic syndrome in women.
Schneider JG; Tompkins C; Blumenthal RS; Mora S
Cardiol Rev; 2006; 14(6):286-91. PubMed ID: 17053375
[TBL] [Abstract][Full Text] [Related]
60. Endometrial adenocarcinoma and polycystic ovary syndrome: risk factors, management, and prognosis.
Elliott JL; Hosford SL; Demopoulos RI; Perloe M; Sills ES
South Med J; 2001 May; 94(5):529-31. PubMed ID: 11372809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
